Skip to content

Clinical trials

Cutaneous Squamous Cell Carcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cutaneous Squamous Cell Carcinoma Country / region: United States Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20071
20111
20121
20132
20141
20151
20172
20181
20198
202010
20217
20225
20236
20245
20252
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting15
Terminated12
Active, not recruiting7
Withdrawn6
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Regeneron Pharmaceuticals5
H. Lee Moffitt Cancer Center and Research Institute4
Memorial Sloan Kettering Cancer Center3
National Cancer Institute (NCI)3
Dana-Farber Cancer Institute2
Incyte Corporation2
Massachusetts General Hospital2
Shattuck Labs, Inc.2
Stanford University2
TuHURA Biosciences, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cutaneous Squamous Cell Carcinoma61
Skin Neoplasms23
Carcinoma, Merkel Cell15
Basal Cell Carcinoma14
Melanoma14
Carcinoma, Squamous Cell13
Squamous Cell Carcinoma of Head and Neck13
Neoplasm Metastasis9
Carcinoma, Non-Small-Cell Lung7
Carcinoma, Renal Cell5

Trials

Showing 26 to 50 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.